The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
GTHP · Healthcare · No moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | DERM | NVCR | GTHP | OSUR |
|---|---|---|---|---|
| Moat Score (0–100) | 37 (highest) | 37 (highest) | 37 (highest) | 36 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 33 | 45 | 60 (highest) | 20 |
| Pricing power | 91 (highest) | 87 | 15 | 72 |
| Returns on capital | 7 | 0 | — | 11 (highest) |
| Balance-sheet safety | 28 | 28 | 28 | 55 (highest) |
| Capital allocation | 24 | 24 | 44 (highest) | 24 |
| No price data | No price data | No price data | No price data | |
| Market cap | $152M | $2.0B | $22.4M | $279M |
| Moat tier | No moat | No moat | No moat | No moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |